Rutgers laboratory helped to create new HIV drug
Thursday, June 23, 2011 - 12:30
in Mathematics & Economics
Two decades after a Rutgers team began working with legendary drug developer Paul Janssen, founder of a Belgian subsidiary of pharmaceutical giant Johnson & Johnson in an effort to create new and potent drugs to fight AIDS, the U.S. Food and Drug Administration has approved the second anti-HIV drug that came from this collaboration.